转化医学
Search documents
滨医附院牵头成立黄河三角洲转化医学中心
Qi Lu Wan Bao· 2025-12-31 10:26
齐鲁晚报.齐鲁壹点陈甜田通讯员蔡国伟 近日,滨州医学院附属医院成功举办黄河三角洲转化医学中心成立大会。滨州市科技局党组书记李宁波、滨州医学院附属医院党委书记王东、滨州中裕食 品有限公司党委书记付蕊出席会议并致辞。滨医附院党委委员、科技处处长李伟主持开幕式。滨州市科学技术局、山东航空学院、滨州职业学院、魏桥国 科高研院、山东省滨州畜牧兽医研究院、滨州市海洋发展研究院以及滨州市相关医疗机构和科技企业的近百名代表参加会议。 李宁波代表市科技局对黄河三角洲转化医学中心的成立表示祝贺,同时也充分肯定了滨医附院的科研积累与创新实践。他指出,中心成立是滨州践行黄河 流域生态保护和高质量发展战略、深化"健康中国"建设的重要举措,标志着我市在推动生物医药产业与临床医学研究融合方面迈出实质性步伐。他希望中 心立足区域特色,聚焦精准医疗与临床需求,产出更多原创成果与可转化技术,为黄河三角洲生物医药与大健康产业高质量发展注入持续动力。 王东在讲话中表示,滨医附院牵头成立黄河三角洲转化医学中心,旨在进一步整合区域内的临床资源、科研力量与产业动能,构建一个开放共享、高效协 同的创新共同体。中心将聚焦重大疾病防治、健康产品研发及临床评价验 ...
中国科学院杭州医学研究所面向全球诚聘英才(研究员、博士后及专业技术人员)
生物世界· 2025-12-25 08:00
编辑丨王多鱼 排版丨水成文 中国科学院杭州医学研究所 :开创精准医疗的未来 中国科学院杭州医学研究所 (HIMCAS) 成立于 2019 年,是中国科学院下属的一家具有前瞻性的医学研 究机构。作为年轻且发展迅速的科技创新中心,HIMCAS 致力于通过将分子发现与临床解决方案相连接来 推动转化医学的突破。我们的使命是加快开发下一代疗法,以应对全球重大健康挑战。 HIMCAS 为处于职业生 涯各个 阶段的研究人员提供了一个充满活力且协作的环境,使他们能够在基础科 学、前沿技术和临床应用的交叉领域开展雄心勃勃的跨学科研究工作。 加入我们不断壮大的研究团队,我们面向全球招募杰出科学家,携手共塑精准医疗的未来。目前开放的职 位包括: 资深研究员 ( Senior PI) , 申请人应目前在国际知名机构担任副教授及以上职位,并具有出色的领导能 力和有影响力的科研成果。 HIMCAS 提供极具竞争力的待遇,包括丰厚的启动资金以及全面的支持来组建 研究团队。成功入选者将有机会招募副研究员 (Co-PI) 、博士后研究员和研究助理,以建立并领导跨学 科项目。 特聘研究员 (Junior PI) ,鼓励在国际知名研究机构任职、已 ...
衢州二院首获 省自然科学基金立项
Xin Lang Cai Jing· 2025-12-24 17:47
(来源:衢州日报) 转自:衢州日报 本报讯 (记者 腊莎 通讯员 姜丽) 近日,浙江省自然科学基金委员会办公室发布2026年度浙江省自然 科学基金自筹经费拟立项项目公示,衢州市第二人民医院(浙大二院衢州分院)申报的《胃肠道应激性 溃疡中高糖环境致免疫细胞代谢重编程的具体研究机制》项目成功入选,斩获立项支持。这是衢州二院 自建院以来首次摘得浙江省自然科学基金项目立项,标志着医院在科研攻关领域实现历史性"零的突 破",为高质量发展注入强劲动能与崭新希望。 浙江省自然科学基金是全省支持基础研究、培育科技人才的核心平台,以高门槛、高竞争、高含金量著 称。此次项目成功突围,印证了衢州二院"医教研协同发展"战略的成效,体现了医院科研实力提升。 依托浙大二院协作资源及"山海"提升工程赋能,衢州二院将科研创新纳入战略重点。通过提前动员、专 家培训、多轮打磨申报材料等举措,医院科研申报质量持续提升,学术氛围日益浓厚。此次立项让全院 备受激励,成为科研发展的重要鞭策。 该项目聚焦临床常见的胃肠道应激性溃疡,探究高糖环境下免疫细胞代谢重编程机制。成果有望填补相 关基础研究空白,为疾病防治提供新思路与靶点,充分体现"从临床中来,到临 ...
以“园中园”破题,成都武侯区的产业创新“智慧”
Mei Ri Jing Ji Xin Wen· 2025-11-13 03:01
Group 1: Overview of Chengdu's Music Industry - Chengdu ranks first among 15 sub-provincial cities in multiple indicators related to music industry concentration and original vitality according to the "2025 China Urban Music Industry Development Index Research Report" [1][3] - The city has seen a surge in music-related activities, with over 23,000 commercial performances and 92 large concerts held from January to September this year, generating ticket revenues exceeding 1.6 billion yuan and driving comprehensive consumption of 7.3 billion yuan [2][3] Group 2: Development of Music Creative Park - The Wuhou District has established a "park within a park" model focusing on copyright protection, original incubation, and industry collaboration, making it one of the fastest-growing music industry regions in the country [1][3] - The Chengdu Music Creative Park has seen a 53.19% year-on-year revenue growth for regulated enterprises in the first three quarters of 2025, highlighting its potential as a hub for music industry growth [4] Group 3: Ecosystem and Future Prospects - The Chengdu Music Creative Park aims to deepen its industry ecosystem centered around copyright economy, artist economy, and performance economy, providing robust support for the city's ambition to become an "International Music Capital" [5] - The park has established a comprehensive service system covering original music creation, market transaction transformation, and copyright protection, with a dedicated team responding to enterprise needs [3][4] Group 4: Integration of Technology and Future Industries - The Wuhou Economic Development Zone is focusing on niche sectors and building a complete industrial chain in the microwave radio frequency industry, which has become a leading cluster in the country [6][7] - The "park within a park" model is being replicated, with the establishment of the Microwave Radio Frequency Science City, which aims to enhance the industrial cluster's capabilities [7][8] Group 5: Health Industry Development - The Wuhou District is also developing a biomedicine "park within a park" model, leveraging resources from West China Hospital to create a comprehensive support system for medical technology transfer [9][10] - The district has attracted over 5,300 health-related enterprises, contributing approximately 11% to the district's GDP, and aims to build a complete and efficient medical service chain [10][11]
济民健康:将博鳌国际医院打造成为高水平的临床研究中心和转化医学平台
Cai Jing Wang· 2025-09-25 09:56
Core Viewpoint - The company is currently facing legal issues related to the forgery of company seals, but its new drug development projects are progressing as planned, and the management is focused on enhancing operational efficiency and market expansion [1] Group 1: Legal and Operational Updates - The police have preliminarily identified the facts regarding the case of forgery involving He Qinghong, who has been arrested by the Huangyan District Procuratorate, with further investigations ongoing [1] - The company assures that its operations are normal and all business segments are developing steadily [1] Group 2: Strategic Initiatives - The management plans to leverage the innovative policies of the Boao Lecheng Pilot Zone to strengthen external collaborations and increase investment in innovative drug research [1] - The company holds a 51% stake in Boao International Hospital, which is intended to be developed into a high-level clinical research center and translational medicine platform [1] Group 3: Future Focus - In the second half of the year, the management will concentrate on the development of existing business segments, enhance market expansion efforts, and optimize asset utilization to improve operational performance and create greater value for shareholders [1]
苏州协和发布B5系列新品
Zhong Guo Jing Ying Bao· 2025-05-14 11:09
Core Insights - Suzhou Concord Pharmaceutical launched its new B5 series products at the "Craftsmanship and Innovation" brand conference in Shanghai, including B5 essence, soothing essence water, soothing essence milk, and soothing cleansing milk [1] - The company initiated the "Guarding Craftsmanship Artisans" campaign in collaboration with People's Daily to infuse cultural connotations into brand development [1] - Suzhou Concord Pharmaceutical is one of the earliest companies in China to develop cosmetics in collaboration with dermatology, starting its journey in 1984 with the Chinese Academy of Medical Sciences [1] Company Strategy - The company emphasizes a commitment to "medical research co-creation," ensuring that every product undergoes clinical validation and consumer feedback [2] - It aims to deepen the construction of a skin database for Chinese consumers, focusing on core ingredients like vitamins and traditional Chinese herbs to address real skincare needs [2] - The mission is to protect the skin health of Chinese people while balancing tradition and innovation, prioritizing consumer trust through professional, safe, and effective products [2]